Enhanced Assisted Reproductive Technology Pregnancy Rate by Prostacyclin Analog (Iloprost)

• Status: Unknown status
• Trial end date: 2013-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

Human fallopian tube secretes high concentration of prostacyclin. Fallopian tube is the site for early embryo development. The effect of prostacyclin on human early embryo development is waiting to be clarified. The study hypothesis is prostacyclin can enhance early embryo development.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Fertility Specialists of Houston
• Collaborator: Origio A/S
• Treatments: Epoprostenol; Iloprost; Tezosentan

Criteria

Inclusion Criteria:

• ART case

Exclusion Criteria:

• age < 40

• no pre-implantation genetic diagnosis procedure